Episodes
Nov. 20, 2024
The biotech reset
Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in th…
Nov. 16, 2024
Future of American healthcare: post-election with Zeke Emanuel
Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appo…
Nov. 1, 2024
Why healthcare is losing its women CEOs
Christina Farr and Ash Zenooz discuss the recent departures of prominent female CEOs from major healthcare companies and explore why progress in female leadership representation has been challenging in the healthcare industr…
Oct. 23, 2024
Curing more than disease: Rob Perez's mission to transform communities
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood interview Rob Perez, founder of Life Science Cares, about his work bridging the biotech industry with poverty alleviation efforts.
Oct. 16, 2024
Stanford Medicine's Dean Dr. Lloyd Minor on the Future of Medical Education
Dr. Lloyd Minor, Dean of Stanford School of Medicine joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss the various transformative advancements and challenges in healthcare.
Oct. 9, 2024
What digital health needs most: Evidence
In this episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood discuss the integration and evaluation of digital tools in healthcare with guest Caroline Pearson from the Peterson Health Technology Institut…
Oct. 2, 2024
Where the jobs are and aren’t in digital health
In this episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood discuss the evolving landscape of healthcare leadership with Oxeon CEO Sonia Millsom.
Sept. 25, 2024
AI's role in diagnosing disease -- with Dr. Isaac Kohane of Harvard Medical School
In this episode of the Second Opinion Podcast, Christina Farr, Ash Zenooz, and Luba Greenwood engage in a candid conversation with Dr. Isaac (Zak) Kohane, a renowned AI expert and chair at Harvard Medical School's Department…
Sept. 18, 2024
Scaling a taboo-breaking business with Origin's CEO Carine Carmy
In this episode of Second Opinion, Christina Farr is joined by Carine Carmy, CEO of Origin to discuss the overlooked aspects of women's healthcare, a case for a physical clinic, and funding stigmatized fields within the comp…
Sept. 11, 2024
The problem with bad therapy — with Alex Katz, Two Chairs CEO
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood dive into the intricacies of the behavioral health industry with Alex Katz, CEO of Two Chairs.
Sept. 4, 2024
All the things we don’t tell women with author Leslie Schrock
In this episode of Second Opinion, Leslie Schrock, author of Bumpin' and Fertility Rules, joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss women's health.
Aug. 28, 2024
Selling into the employer is harder than it's ever been with Included Health's Owen Tripp
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood sit down with Owen Tripp, the CEO of Included Health. They discuss the challenges of selling digital health solutions to employers, the…
Aug. 21, 2024
Raising from VC and PE in Health Tech with Meg FitzGerald of Grey Ghost Capital
In this episode of Second Opinion, Meg FitzGerald, a nurse turned private equity investor, offers insights into how VCs and PEs are thinking of investing in healthcare and everything founders should know to raise from both.
Aug. 14, 2024
Big tech's healthcare hurdles with Sumit Nagpal, CEO of Cherish
In this eye-opening episode, Christina Farr and Luba Greenwood dive deep into the challenges big tech faces in healthcare with serial entrepreneur and Cherish CEO Sumit Nagpal.
Aug. 7, 2024
Breaking down biotech with Daphne Zohar: VC dynamics, drug development, and the Biosecure Act
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Daphne Zohar, CEO of Seaport Therapeutics.
July 31, 2024
Whose job is it to prevent chronic disease? with Dr. Robin Berzin, Founder & CEO of Parsley Health
On the first episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood chat with Dr. Robin Berzin, the Founder & CEO of Parsley Health.
